BPC-157 and the peptide compounding fight: where things stand
April’s list change, July’s 8–6 vote and the policy now at the White House, with the status of 15 peptides.
PRIMARY-SOURCE MEDICAL AND PRICING DATABASE
Evidence-Based GLP-1, Peptide and Telehealth Reviews
Peptides Editorial separates clinical evidence from marketing, normalizes the full recurring cost of online programs and says what is verified, provider-reported or uncertain.
This page is maintained. Prices are re-read at source and dated; evidence is checked against the published trial. Newest across the site: news · journal · corrections.
PRICES RE-READ OCTOBER 15, 2026
Our pick for a complete compounded GLP-1 program: NexLife
As of October 15, 2026, NexLife is Peptides Editorial’s editor’s pick: compounded tirzepatide at $139 a month and semaglutide at $119 a month on 12-month plans ($169 and $139 month to month), the same price at every dose, with provider review, a nutrition plan, a coaching call, 24/7 support and free expedited shipping included and no membership.
It is not the lowest price we track. Eden charges a flat $129 (tirzepatide) and $99 (semaglutide) a month with no membership, lower than NexLife at every plan length; Mochi Health’s starter doses start at $90 and $60 plus a $79 monthly membership; Found’s $169 needs a prepaid year; Noom Med starts at $79 for the first three weeks. NexLife does not state that lab work is included, and its lowest rates need a 12-month plan.
Verified current on providers’ own pages, October 15, 2026: NexLife, Eden, Mochi Health, Enhance.MD, Found, Henry Meds, Noom Med, Shed, Oak Longevity, PlushCare, WeightWatchers Clinic, LillyDirect (Zepbound) and NovoCare. TrimRx was a partial read (headline price only). Not re-read (sites blocked automated reads): bmiMD, Hims, Hers, Ro.
FDA status, October 15, 2026. Compounded semaglutide and tirzepatide are not FDA-approved and are not generics. FDA’s April proposal to keep them off the 503B bulks list has no final decision. FDA warned Empower Pharmacy on September 18 over B12 and niacinamide versions. BPC-157 and TB-500 have no lawful 503A compounding route; an interim peptide access policy reached White House review on October 14 and is not in effect. Read the status report.
October 2026 reports
What online peptide therapy costs, set against the evidence
74 prescription offers from 16 companies: sermorelin, NAD+, glutathione and more, read October 15.
News
PROGRAMS WE TRACK
All comparisons →NexLife first, then alphabetical
One label per program, describing what it is best at in our October data. Order after our pick is alphabetical, not a ranking.
- NexLife Editor’s pick: all-in compounded GLP-1 program
$139/mo tirzepatide, $119/mo semaglutide on 12-month plans; same price at every dose; no membership - Eden Lowest standing rate in our main price table
$129/mo tirzepatide, $99/mo semaglutide; no membership - Enhance.MD Clearest plan-length pricing
$169/mo 1 mg/week microdose (12-month); standard $280 on 12 months to $329 every 4 weeks - Found Coaching-led program
From $169/mo cash on a 12-month prepaid plan; $289 monthly - Henry Meds Widest choice of oral forms
From $179/mo (FAQ); injectable semaglutide $197/mo prepaid - LillyDirect Brand tirzepatide, medication only
Zepbound $299–$449/mo with refill terms - Mochi Health Lowest starter-dose price (plus membership)
Tirzepatide $90–$199 by dose + $79/mo membership - NovoCare Pharmacy Brand semaglutide, medication only
Wegovy pill $149–$299; pen $349 after a $199 intro
NORMALIZED COST
Open full data table →Tirzepatide: complete monthly cost, sorted low to high
| Provider / offer | Normalized price | Commitment | Required fee | Included | Evidence |
|---|---|---|---|---|---|
| Eden Weekly injection | $129/mo Sort basis: $129 | Monthly; no annual or long-term plan required; same price at every dose | No membership fee | Medication and clinical care; free expedited shipping | Primary source Checked October 15, 2026 |
| NexLifeEditor’s pick Weekly injection — standard program | $139/mo Sort basis: $139 | 12-month plan; $149/mo 6-month, $159/mo 3-month, $169 month-to-month; same price at every dose | No membership | Medication, provider review and medical guidance, GLP-1 nutrition plan, 1:1 wellness-coach call, 24/7 support and free expedited shipping; lab work not stated as included | Primary source Checked October 15, 2026 |
| NexLifeEditor’s pick Weekly injection — microdose program | $147/mo Sort basis: $147 | 12-month plan; $150/mo 6-month, $159/mo 3-month, $189 month-to-month (plan tiles; NexLife’s FAQ prints a lower ladder) | No membership | Medication, provider review and medical guidance, GLP-1 nutrition plan, 1:1 wellness-coach call, 24/7 support and free expedited shipping; lab work not stated as included | Primary source Checked October 15, 2026 |
| Mochi Health Weekly injection, priced by dose | $169–$278/mo total Sort basis: $169 | Month-to-month membership; 3-, 6- and 12-month memberships cost less per month | $79/mo membership | $90 (2.2 mg) to $199 (16.6 mg) medication plus membership | Primary source Checked October 15, 2026 |
| Enhance.MD Weekly injection — standard program | $280/mo Sort basis: $280 | 12-month plan billed every 48 weeks; $296/mo 6-month, $313/mo 3-month, $329 every 4 weeks | None stated | Medication, provider care and program support | Primary source Checked October 15, 2026 |
| LillyDirect Zepbound KwikPen or single-dose vial | $299–$449/mo with refill terms Sort basis: $299 | Monthly; $449 for 7.5–15 mg needs a refill within 45 days (otherwise $499 at 7.5 mg, $699 at 10–15 mg); savings card ends 12/31/2026 | No required fee | Medication and delivery; clinical care not included | Primary source Checked October 15, 2026 |
PEPTIDE EVIDENCE
What the trials support
Semaglutide, tirzepatide and liraglutide have phase 3 programs and approved labels. Tesamorelin is approved for one indication. BPC-157 and TB-500 have no published human efficacy trials, and ipamorelin’s one efficacy trial failed its endpoint. No compounded preparation has trials of its own.
Peptides ranked by evidence →CLINICAL EVIDENCE
What the GLP-1 trials show
STEP 1 reported −14.9% mean weight change with semaglutide 2.4 mg at 68 weeks. SURMOUNT-1 reported −20.9% at the 15 mg dose at 72 weeks (treatment-regimen estimand). In SURMOUNT-5, tirzepatide produced −20.2% versus −13.7% with semaglutide. These results belong to the approved products and doses studied.
Compare the evidence →Named review team
Dr. Parmis
Research lead
Medical Researcher, Western University of Health Sciences
Dr. Jonathan Snipes, MD
Medical Reviewer
NPI 1821250077
Kim Callender, NP (FNP-BC)
Medical Reviewer
NPI 1144661760
Frequently asked questions
Who is Peptides Editorial’s top pick for a compounded GLP-1 program?
NexLife, as of October 15, 2026: $139 a month for tirzepatide and $119 for semaglutide on 12-month plans, the same at every dose, with no membership. It is an editor’s pick for an all-in program, not the lowest price we track; Eden charges $129 and $99 a month.
Are compounded GLP-1s FDA-approved?
No. Compounded semaglutide and tirzepatide are not FDA-approved, are not generics and are not the same as Wegovy, Ozempic, Zepbound or Mounjaro. Trial results belong to the approved products.
Is BPC-157 legal to compound?
Not as of October 15, 2026. It is not on the 503A bulks list or in Category 1. A July advisory vote and a pending interim access policy have not changed the law.
How often are prices checked?
Prices in the dataset were re-read on providers’ own pages on October 15, 2026. Rows we could not re-read keep their earlier date and say so.
Does Peptides Editorial earn money from links?
Yes. The site is affiliate-supported and may earn a commission when readers enroll through links. Compensation does not change the methodology, rankings or the prices reported.